• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃博拉干扰素抑制结构域会减弱并失调细胞介导的免疫反应。

The Ebola Interferon Inhibiting Domains Attenuate and Dysregulate Cell-Mediated Immune Responses.

作者信息

Lubaki Ndongala Michel, Younan Patrick, Santos Rodrigo I, Meyer Michelle, Iampietro Mathieu, Koup Richard A, Bukreyev Alexander

机构信息

Department of Pathology, the University of Texas Medical Branch, Galveston, Texas, United States of America.

Galveston National Laboratory, the University of Texas Medical Branch, Galveston, Texas, United States of America.

出版信息

PLoS Pathog. 2016 Dec 8;12(12):e1006031. doi: 10.1371/journal.ppat.1006031. eCollection 2016 Dec.

DOI:10.1371/journal.ppat.1006031
PMID:27930745
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5145241/
Abstract

Ebola virus (EBOV) infections are characterized by deficient T-lymphocyte responses, T-lymphocyte apoptosis and lymphopenia. We previously showed that disabling of interferon-inhibiting domains (IIDs) in the VP24 and VP35 proteins effectively unblocks maturation of dendritic cells (DCs) and increases the secretion of cytokines and chemokines. Here, we investigated the role of IIDs in adaptive and innate cell-mediated responses using recombinant viruses carrying point mutations, which disabled IIDs in VP24 (EBOV/VP24m), VP35 (EBOV/VP35m) or both (EBOV/VP35m/VP24m). Peripheral blood mononuclear cells (PBMCs) from cytomegalovirus (CMV)-seropositive donors were inoculated with the panel of viruses and stimulated with CMV pp65 peptides. Disabling of the VP35 IID resulted in increased proliferation and higher percentages of CD4+ T cells secreting IFNγ and/or TNFα. To address the role of aberrant DC maturation in the IID-mediated suppression of T cell responses, CMV-stimulated DCs were infected with the panel of viruses and co-cultured with autologous T-lymphocytes. Infection with EBOV/VP35m infection resulted in a significant increase, as compared to wt EBOV, in proliferating CD4+ cells secreting IFNγ, TNFα and IL-2. Experiments with expanded CMV-specific T cells demonstrated their increased activation following co-cultivation with CMV-pulsed DCs pre-infected with EBOV/VP24m, EBOV/VP35m and EBOV/VP35m/VP24m, as compared to wt EBOV. Both IIDs were found to block phosphorylation of TCR complex-associated adaptors and downstream signaling molecules. Next, we examined the effects of IIDs on the function of B cells in infected PBMC. Infection with EBOV/VP35m and EBOV/VP35m/VP24m resulted in significant increases in the percentages of phenotypically distinct B-cell subsets and plasma cells, as compared to wt EBOV, suggesting inhibition of B cell function and differentiation by VP35 IID. Finally, infection with EBOV/VP35m increased activation of NK cells, as compared to wt EBOV. These results demonstrate a global suppression of cell-mediated responses by EBOV IIDs and identify the role of DCs in suppression of T-cell responses.

摘要

埃博拉病毒(EBOV)感染的特征是T淋巴细胞反应不足、T淋巴细胞凋亡和淋巴细胞减少。我们之前表明,使VP24和VP35蛋白中的干扰素抑制结构域(IIDs)失活可有效解除树突状细胞(DCs)的成熟阻滞,并增加细胞因子和趋化因子的分泌。在此,我们使用携带点突变的重组病毒研究了IIDs在适应性和先天性细胞介导反应中的作用,这些点突变使VP24(EBOV/VP24m)、VP35(EBOV/VP35m)或两者(EBOV/VP35m/VP24m)中的IIDs失活。用该组病毒接种来自巨细胞病毒(CMV)血清学阳性供体的外周血单个核细胞(PBMCs),并用CMV pp65肽进行刺激。VP35 IID的失活导致分泌IFNγ和/或TNFα的CD4 + T细胞增殖增加且百分比更高。为了研究异常DC成熟在IID介导的T细胞反应抑制中的作用,用该组病毒感染CMV刺激的DCs,并与自体T淋巴细胞共培养。与野生型EBOV相比,EBOV/VP35m感染导致分泌IFNγ、TNFα和IL-2的增殖CD4 +细胞显著增加。对扩增的CMV特异性T细胞进行的实验表明,与野生型EBOV相比,它们在与预先感染EBOV/VP24m、EBOV/VP35m和EBOV/VP35m/VP24m的CMV脉冲DCs共培养后激活增加。发现两个IIDs均阻断TCR复合物相关衔接子和下游信号分子的磷酸化。接下来,我们研究了IIDs对感染的PBMC中B细胞功能的影响。与野生型EBOV相比,EBOV/VP35m和EBOV/VP35m/VP24m感染导致表型不同的B细胞亚群和浆细胞百分比显著增加,提示VP35 IID抑制B细胞功能和分化。最后,与野生型EBOV相比,EBOV/VP35m感染增加了NK细胞的激活。这些结果证明了EBOV IIDs对细胞介导反应的全面抑制,并确定了DCs在抑制T细胞反应中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a606/5145241/12fbea76a210/ppat.1006031.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a606/5145241/c74a3be4d8a2/ppat.1006031.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a606/5145241/de6fb3e3904e/ppat.1006031.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a606/5145241/bcbb58e8219b/ppat.1006031.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a606/5145241/6c8a0b2640ff/ppat.1006031.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a606/5145241/a70c8ac834c7/ppat.1006031.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a606/5145241/a760d326b569/ppat.1006031.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a606/5145241/3f041c8a7842/ppat.1006031.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a606/5145241/695cdd2751c5/ppat.1006031.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a606/5145241/61610a7852e5/ppat.1006031.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a606/5145241/12fbea76a210/ppat.1006031.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a606/5145241/c74a3be4d8a2/ppat.1006031.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a606/5145241/de6fb3e3904e/ppat.1006031.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a606/5145241/bcbb58e8219b/ppat.1006031.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a606/5145241/6c8a0b2640ff/ppat.1006031.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a606/5145241/a70c8ac834c7/ppat.1006031.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a606/5145241/a760d326b569/ppat.1006031.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a606/5145241/3f041c8a7842/ppat.1006031.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a606/5145241/695cdd2751c5/ppat.1006031.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a606/5145241/61610a7852e5/ppat.1006031.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a606/5145241/12fbea76a210/ppat.1006031.g010.jpg

相似文献

1
The Ebola Interferon Inhibiting Domains Attenuate and Dysregulate Cell-Mediated Immune Responses.埃博拉干扰素抑制结构域会减弱并失调细胞介导的免疫反应。
PLoS Pathog. 2016 Dec 8;12(12):e1006031. doi: 10.1371/journal.ppat.1006031. eCollection 2016 Dec.
2
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells.埃博拉病毒VP35和VP24蛋白对人树突状细胞中全球基因表达的不同时间效应
J Virol. 2015 Aug;89(15):7567-83. doi: 10.1128/JVI.00924-15. Epub 2015 May 13.
3
Transcriptional Analysis of Lymphoid Tissues from Infected Nonhuman Primates Reveals the Basis for Attenuation and Immunogenicity of an Ebola Virus Encoding a Mutant VP35 Protein.从感染的非人类灵长类动物的淋巴组织转录分析揭示了编码突变 VP35 蛋白的埃博拉病毒减毒和免疫原性的基础。
J Virol. 2021 Feb 24;95(6). doi: 10.1128/JVI.01995-20.
4
A VP35 Mutant Ebola Virus Lacks Virulence but Can Elicit Protective Immunity to Wild-Type Virus Challenge.一种 VP35 突变埃博拉病毒缺乏毒力但能诱导针对野生型病毒攻击的保护性免疫。
Cell Rep. 2019 Sep 17;28(12):3032-3046.e6. doi: 10.1016/j.celrep.2019.08.047.
5
The lack of maturation of Ebola virus-infected dendritic cells results from the cooperative effect of at least two viral domains.埃博拉病毒感染树突状细胞不成熟是至少两个病毒结构域协同作用的结果。
J Virol. 2013 Jul;87(13):7471-85. doi: 10.1128/JVI.03316-12. Epub 2013 Apr 24.
6
Insights into Ebola Virus VP35 and VP24 Interferon Inhibitory Functions and their Initial Exploitation as Drug Targets.深入了解埃博拉病毒VP35和VP24的干扰素抑制功能及其作为药物靶点的初步开发
Infect Disord Drug Targets. 2019;19(4):362-374. doi: 10.2174/1871526519666181123145540.
7
Effects of Filovirus Interferon Antagonists on Responses of Human Monocyte-Derived Dendritic Cells to RNA Virus Infection.丝状病毒干扰素拮抗剂对人单核细胞衍生树突状细胞对RNA病毒感染反应的影响。
J Virol. 2016 Apr 29;90(10):5108-5118. doi: 10.1128/JVI.00191-16. Print 2016 May 15.
8
The VP35 protein of Ebola virus impairs dendritic cell maturation induced by virus and lipopolysaccharide.埃博拉病毒的 VP35 蛋白可损害病毒和脂多糖诱导的树突状细胞成熟。
J Gen Virol. 2010 Feb;91(Pt 2):352-61. doi: 10.1099/vir.0.017343-0. Epub 2009 Oct 14.
9
Evasion of interferon responses by Ebola and Marburg viruses.埃博拉和马尔堡病毒对干扰素反应的逃避。
J Interferon Cytokine Res. 2009 Sep;29(9):511-20. doi: 10.1089/jir.2009.0076.
10
Molecular basis for ebolavirus VP35 suppression of human dendritic cell maturation.埃博拉病毒VP35抑制人树突状细胞成熟的分子基础
J Virol. 2014 Nov;88(21):12500-10. doi: 10.1128/JVI.02163-14. Epub 2014 Aug 20.

引用本文的文献

1
A comparative analysis of Marburg virus-infected bat and human models from public high-throughput sequencing data.基于公开高通量测序数据的马尔堡病毒感染蝙蝠和人类模型的比较分析。
Int J Med Sci. 2025 Jan 1;22(1):1-16. doi: 10.7150/ijms.100696. eCollection 2025.
2
Natural killer cells and their exosomes in viral infections and related therapeutic approaches: where are we?自然杀伤细胞及其细胞外囊泡在病毒感染及相关治疗方法中的作用:我们的研究进展如何?
Cell Commun Signal. 2023 Sep 25;21(1):261. doi: 10.1186/s12964-023-01266-2.
3
Animal Model Alternatives in Filovirus and Bornavirus Research.

本文引用的文献

1
Kinetic Analysis of Biomarkers in a Cohort of US Patients With Ebola Virus Disease.美国埃博拉病毒病患者队列中生物标志物的动力学分析。
Clin Infect Dis. 2016 Aug 15;63(4):460-7. doi: 10.1093/cid/ciw334. Epub 2016 Jun 27.
2
Unique human immune signature of Ebola virus disease in Guinea.几内亚埃博拉病毒病独特的人类免疫特征。
Nature. 2016 May 5;533(7601):100-4. doi: 10.1038/nature17949.
3
Type I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricide.I型干扰素通过保护自然杀伤细胞免受自相残杀,在病毒感染期间促进自然杀伤细胞的扩增。
动物模型在丝状病毒和博尔纳病毒研究中的应用。
Viruses. 2023 Jan 4;15(1):158. doi: 10.3390/v15010158.
4
Role of Siglecs in viral infections: A double-edged sword interaction.Siglecs 在病毒感染中的作用:一把双刃剑的相互作用。
Mol Aspects Med. 2023 Apr;90:101113. doi: 10.1016/j.mam.2022.101113. Epub 2022 Aug 16.
5
RNA Viruses, Pregnancy and Vaccination: Emerging Lessons from COVID-19 and Ebola Virus Disease.RNA病毒、妊娠与疫苗接种:来自新冠病毒病和埃博拉病毒病的新经验教训
Pathogens. 2022 Jul 15;11(7):800. doi: 10.3390/pathogens11070800.
6
Ebola virus protein VP40 stimulates IL-12- and IL-18-dependent activation of human natural killer cells.埃博拉病毒蛋白 VP40 刺激人自然杀伤细胞依赖 IL-12 和 IL-18 的激活。
JCI Insight. 2022 Aug 22;7(16):e158902. doi: 10.1172/jci.insight.158902.
7
Hyperinflammation, apoptosis, and organ damage.过度炎症、细胞凋亡和器官损伤。
Exp Biol Med (Maywood). 2022 Jul;247(13):1112-1123. doi: 10.1177/15353702221090454. Epub 2022 Apr 27.
8
Lymphopenia Caused by Virus Infections and the Mechanisms Beyond.病毒感染引起的淋巴细胞减少症及其机制。
Viruses. 2021 Sep 20;13(9):1876. doi: 10.3390/v13091876.
9
Pathogenicity and Virulence of Ebolaviruses with Species- and Variant-specificity.埃博拉病毒的物种和变体特异性的致病性和毒力。
Virulence. 2021 Dec;12(1):885-901. doi: 10.1080/21505594.2021.1898169.
10
Natural killer cell responses to emerging viruses of zoonotic origin.自然杀伤细胞对人畜共患起源的新兴病毒的反应。
Curr Opin Virol. 2020 Oct;44:97-111. doi: 10.1016/j.coviro.2020.07.003. Epub 2020 Aug 9.
J Exp Med. 2016 Feb 8;213(2):225-33. doi: 10.1084/jem.20150712. Epub 2016 Jan 11.
4
Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus.丝状病毒发病机制与免疫逃逸:来自埃博拉病毒和马尔堡病毒的见解
Nat Rev Microbiol. 2015 Nov;13(11):663-76. doi: 10.1038/nrmicro3524. Epub 2015 Oct 6.
5
Transcriptional Profiling of the Immune Response to Marburg Virus Infection.马尔堡病毒感染免疫反应的转录谱分析
J Virol. 2015 Oct;89(19):9865-74. doi: 10.1128/JVI.01142-15. Epub 2015 Jul 22.
6
Aerosolized Ebola vaccine protects primates and elicits lung-resident T cell responses.雾化埃博拉疫苗可保护灵长类动物并引发肺驻留T细胞反应。
J Clin Invest. 2015 Aug 3;125(8):3241-55. doi: 10.1172/JCI81532. Epub 2015 Jul 13.
7
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells.埃博拉病毒VP35和VP24蛋白对人树突状细胞中全球基因表达的不同时间效应
J Virol. 2015 Aug;89(15):7567-83. doi: 10.1128/JVI.00924-15. Epub 2015 May 13.
8
Human Ebola virus infection results in substantial immune activation.人类感染埃博拉病毒会导致大量免疫激活。
Proc Natl Acad Sci U S A. 2015 Apr 14;112(15):4719-24. doi: 10.1073/pnas.1502619112. Epub 2015 Mar 9.
9
Type I interferons in infectious disease.传染病中的I型干扰素。
Nat Rev Immunol. 2015 Feb;15(2):87-103. doi: 10.1038/nri3787.
10
Molecular basis for ebolavirus VP35 suppression of human dendritic cell maturation.埃博拉病毒VP35抑制人树突状细胞成熟的分子基础
J Virol. 2014 Nov;88(21):12500-10. doi: 10.1128/JVI.02163-14. Epub 2014 Aug 20.